Release Date: 30/04/20 15:29 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 119.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%